Rising consumer demand for fewer empty calories is pushing the snack and beverage giant to offer options with less sodium, fat and artificial ingredients.

CEO Ramon Laguarta said the Doritos maker hasn’t seen a “direct impact” from GLP-1 medications despite a higher level of awareness among consumers toward health and wellness.

As expected, PepsiCo ( PEP) saw business disruptions across certain markets due to international conflicts and geopolitical tensions, factors which are expected to persist in 2025. Management's commentary on the impact of weight loss drugs indicates that the company may look to add more healthy snacks to its portfolio.